Advertisement
Advertisement
SCNX
Scienture Holdings, Inc. Common Stock
3.04
USDSponsored
-0.16
-5.00%
Nov 10, 15:59 UTC -5
Closed
After-Market
3.06
+0.02
+0.72%
Scienture Holdings, Inc. Common Stock (SCNX) Earnings
SCNX Earnings Reports
Positive Surprise Ratio
SCNX beat 11 of 22 last estimates.
50%
Next Report
Date of Next Report
Mar 29, 2027
Estimate for Q4 26 (Revenue/ EPS)
$2.06M
/-$0.37
Implied change from Q3 26 (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/-86.55%
Scienture Holdings, Inc. Common Stock earnings per share and revenue
On Oct 13, 2026, SCNX reported earnings of -- USD per share (EPS) for Q3 26, -- the estimate of -1.60 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 1.24 million, with a --% difference.
Looking ahead to Q4 26, -- analysts forecast an EPS of -0.37 USD, with revenue projected to reach 2.06 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Definium Therapeutics, Inc. Common Shares
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.56
Actual
-$0.46
Surprise
+19.06%
Ocular Therapeutix, Inc.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.36
Actual
-$0.42
Surprise
-13.54%
Harrow, Inc. Common Stock
Report Date
Nov 09, 2026 For Q3 26
Estimate
$0.22
Actual
$0.12
Surprise
-45.92%
SIGA Technologies Inc.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-Actual
-$0.04
Surprise
-
Protara Therapeutics, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.35
Surprise
+6.17%
Minerva Neurosciences, Inc
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.12
Actual
$1.94
Surprise
+1,629.97%
Tonix Pharmaceuticals Holding Corp.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$2.40
Actual
-$2.89
Surprise
-20.23%
Cumberland Pharmaceuticals Inc
Report Date
Nov 10, 2026 For Q3 26
Estimate
-Actual
-$0.07
Surprise
-
PMV Pharmaceuticals, Inc
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.34
Actual
-$0.28
Surprise
+15.55%
Corbus Pharmaceuticals Holdings, Inc.
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$1.23
Actual
-$1.81
Surprise
-46.07%
FAQ
What were Scienture Holdings, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Scienture Holdings, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Scienture Holdings, Inc. Common Stock's Q3 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Scienture Holdings, Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 29, 2027.
What are the forecasts for Scienture Holdings, Inc. Common Stock's next earnings report?
Based on --
analysts, Scienture Holdings, Inc. Common Stock is expected to report EPS of -$0.37 and revenue of $2.06M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.